Cargando…

Continuous infusion versus intermittent infusion of vancomycin in critically ill patients undergoing continuous venovenous hemofiltration: a prospective interventional study

BACKGROUND: A prospective interventional study comparing outcomes in critically ill patients receiving intermittent infusion (II) or continuous infusion (CI) of vancomycin during continuous venovenous hemofiltration (CVVH) is lacking. The objective of this study was to compare the pharmacokinetic/ph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinhui, Duan, Lufen, Li, Jiahui, Chen, Fang, Xu, Xiaowen, Lu, Jian, Zhuang, Zhiwei, Cao, Yifei, Yuan, Yunlong, Liu, Xin, Sun, Jiantong, Zhou, Qin, Shi, Lu, Tang, Lian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344630/ https://www.ncbi.nlm.nih.gov/pubmed/35918657 http://dx.doi.org/10.1186/s12879-022-07618-6

Ejemplares similares

Vancomycin continuous infusion versus intermittent infusion during continuous venovenous hemofiltration: slow and steady may win the race
por: Lin, Hsin, et al.
Publicado: (2015)

Intermittent versus continuous enoxaparine for anticoagulation during continuous venovenous hemofiltration
por: Koroljov, A, et al.
Publicado: (2008)

Effects of continuous venovenous hemofiltration on vancomycin trough concentrations in critically ill children
por: Peng, Lengyue, et al.
Publicado: (2021)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

The effects of continuous venovenous hemofiltration on coagulation activation
por: Bouman, Catherine SC, et al.
Publicado: (2006)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Influence of continuous venovenous hemofiltration on transpulmonary thermodilution-derived parameters
por: Neirynck, V, et al.
Publicado: (2009)

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase
por: Connors, Nicholas J., et al.
Publicado: (2014)

Bioenergetic Balance of Continuous Venovenous Hemofiltration, a Retrospective Analysis
por: Jonckheer, Joop, et al.
Publicado: (2022)

Comparing adsorption of gentamicin by polyacrylonitrile and polyamide hemofiltration filter in an in vitro continuous venovenous hemofiltration model
por: Lam, P, et al.
Publicado: (2009)

Pharmacokinetics of gentamicin and vancomycin during continuous venovenous hemofiltration in critically ill septic patients with acute kidney injury
por: Petejova, N, et al.
Publicado: (2013)

Immunomodulatory Effect of Continuous Venovenous Hemofiltration during Sepsis: Preliminary Data
por: Servillo, Giuseppe, et al.
Publicado: (2013)

Administration of Vancomycin at High Doses in Patients with Post Neurosurgical Meningitis: A Comprehensive Comparison between Continuous Infusion and Intermittent Infusion
por: Taheri, Morteza, et al.
Publicado: (2018)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study
por: de Pont, Anne-Cornélie JM, et al.
Publicado: (2007)

High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal
por: Grafft, Carrie, et al.
Publicado: (2011)

Comparison of intermittent versus continuous-infusion vancomycin for treating severe patients in intensive care units
por: Yamada, Carolina Hikari, et al.
Publicado: (2020)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

Dose Optimization of Teicoplanin for Critically Ill Patients With Renal Dysfunction and Continuous Renal Replacement Therapy: Experience From a Prospective Interventional Study
por: Shi, Lu, et al.
Publicado: (2022)

Metabolism of Albumin after Continuous Venovenous Hemofiltration in Patients with Systemic Inflammatory Response Syndrome
por: Chen, Yu, et al.
Publicado: (2015)

Metabolic Acidosis and Hyperlactatemia Requiring Continuous Venovenous Hemofiltration after Intentional Ingestion of Metformin
por: Cruz, Maricel Dela, et al.
Publicado: (2021)

Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study
por: Sun, Zhiping, et al.
Publicado: (2014)

Continuous infusion versus intermittent infusion of ceftazidime for the treatment of pneumonia caused by Pseudomonas aeruginosa
por: Lorente, L, et al.
Publicado: (2005)

Prognostic comparison of goal-oriented hemoperfusion and routine hemoperfusion combined with continuous venovenous hemofiltration for paraquat poisoning
por: Zhao, Xuming, et al.
Publicado: (2017)

Continuous venovenous hemofiltration in severely burned patients with acute kidney injury: a cohort study
por: Chung, Kevin K, et al.
Publicado: (2009)

Experience with continuous venovenous hemofiltration (CVVH) in the ICU: a report from a single center
por: Nalbandi, V, et al.
Publicado: (2001)

Evaluation of the potential adverse effects associated with calcium carbonate precipitate during continuous venovenous hemofiltration
por: McKee, J, et al.
Publicado: (2012)

The Effect of Bicarbonate Administration via Continuous Venovenous Hemofiltration on Acid-Base Parameters in Ventilated Patients
por: Allegretti, Andrew S., et al.
Publicado: (2015)

Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia
por: Paquette, François, et al.
Publicado: (2016)

Continuous venovenous hemofiltration in the management of paraquat poisoning: A meta-analysis of randomized controlled trials
por: Lin, Guodong, et al.
Publicado: (2017)

769. Comparison of Vancomycin Continuous and Intermittent Infusion Dosing Strategies Among Patients in an Outpatient Antimicrobial Therapy Program
por: Shakeraneh, Pegah, et al.
Publicado: (2019)

Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
por: Xu, Lengnan, et al.
Publicado: (2023)

Efficacy and Safety of Continuous Infusion of Vancomycin in Children: A Systematic Review
por: Alonso-Moreno, Marta, et al.
Publicado: (2021)

Determinants of Outcome in Non-Septic Critically Ill Patients with Acute Kidney Injury on Continuous Venovenous Hemofiltration
por: Koning, Mark V., et al.
Publicado: (2011)

A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
por: Leung, Anne Kit-Hung, et al.
Publicado: (2013)

High-volume continuous venovenous hemofiltration reduces mortality in critically ill patients with acute renal failure
por: Van Ketel, R, et al.
Publicado: (2008)

Severe Carbamazepine Toxicity Treated with Continuous Venovenous Hemofiltration at Palestine Medical Complex: Two Case Reports
por: Nasif, Mowaffaq A, et al.
Publicado: (2022)

Severe Metformin Poisoning Successfully Treated with Simultaneous Venovenous Hemofiltration and Prolonged Intermittent Hemodialysis
por: Leonaviciute, Dovile, et al.
Publicado: (2018)

Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_oj2jl04ulig9u27sbass6r53eb